Crescent Biopharma, Inc. Liquidation Value
CBIO
Other
Cash & Equivalents
$213.19M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $213.19M
Total Obligations: -$37.72M
$175.48M
Per share: $6.37
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $213.19M
AR: $18.00M
Total Obligations: -$37.72M
$193.48M
Per share: $7.02
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $213.19M
AR: $18.00M
Inventory: $0
Total Obligations: -$37.72M
$193.48M
Per share: $7.02
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $175.48M | $6.37 |
| Liquid Liquidation Value | $193.48M | $7.02 |
| Operating Liquidation Value | $193.48M | $7.02 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $213.19M |
| Accounts Receivable | $18.00M |
| Inventory | N/A |
| Current Liabilities | $36.07M |
| Long-term Debt | N/A |
| Op. Lease Liability | $1.64M |
| Finance Lease | N/A |
| Shares Outstanding | 27.6M |
Explore all 155 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $213.19M | $18.00M | N/A | N/A | $36.07M | N/A | $1.64M | N/A |
| 2025-09-30 | $133.26M | N/A | N/A | N/A | $20.30M | N/A | $1.74M | N/A |
| 2025-06-30 | $458.36M | N/A | N/A | N/A | $16.75M | N/A | $1.64M | N/A |
| 2025-03-31 | $5.61M | $78,762 | N/A | $104,671 | $2.62M | N/A | N/A | N/A |
| 2024-12-31 | $34.77M | $0 | N/A | $329,304 | $9.61M | N/A | $66,844 | N/A |
| 2024-09-30 | $14.39M | $50,255 | N/A | $581,794 | $4.32M | N/A | $262,133 | N/A |
| 2024-09-19 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| 2024-09-18 | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
▼ Community Notes